Directory

>

Ralph Tiedt

avatar

Ralph Tiedt

VP Oncology | Monte Rosa Therapeutics

Basel, Basel-City, Switzerland

View contact details (it's free)

Ralph Tiedt

Summary

Ralph Tiedt is a highly accomplished VP of Biology at Monte Rosa Therapeutics, with a rich background in drug discovery and oncology. He obtained his PhD from the prestigious Friedrich Miescher Institute, focusing on immunology and transcriptional regulation in B cells. His career highlights include significant contributions to the discovery of the JAK2 mutation, which has influenced therapeutic development in myeloproliferative neoplasms. Ralph has held various leadership roles at Novartis, where he has led drug discovery projects and mentored numerous students and postdocs. His expertise spans both translational research and team leadership in oncology. Ralph is passionate about advancing cancer therapies and fostering the next generation of researchers. He is fluent in English and has a deep commitment to innovation in the biomedical field. Outside of his professional endeavors, he enjoys mentoring and sharing knowledge with upcoming scientists.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Ralph Tiedt

Work Experience

company logo

VP Oncology at

Monte Rosa Therapeutics

October 2022 - Present

company logo

Associate Director in Oncology Translational Research at

Novartis

April 2015 - Present

company logo

Senior Director of Target and Drug Discovery at

Monte Rosa Therapeutics

September 2021 - September 2022

company logo

(Senior) Investigator in Oncology Drug Discovery at

Novartis

March 2008 - March 2015

company logo

Postdoctoral Fellow at

Universitätsspital Basel

January 2004 - February 2008

Logos provided by Logo.dev

Ralph Tiedt

Education

Friedrich Miescher Institute, Doctor Of Philosophy (Phd)

January 1998 - January 2003

Universität Basel, Diploma

January 1996 - January 1998

Frequently Asked Questions about Ralph Tiedt

What is Ralph Tiedt email address?

Ralph Tiedt's primary email address is ***********@novartis.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Ralph Tiedt work for?

Ralph Tiedt is a VP Oncology at Monte Rosa Therapeutics, a company specializing in Commercial physical research.

Where Ralph Tiedt graduated from?

Ralph Tiedt holds a degree in from Friedrich Miescher Institute.

How can I directly contact Ralph Tiedt?

To contact Ralph Tiedt directly, you can use the email address ***********@novartis.com. Complete contact information is available upon registration with Muraena.

Who is Ralph Tiedt?

Ralph Tiedt is a highly accomplished VP of Biology at Monte Rosa Therapeutics, with a rich background in drug discovery and oncology. He obtained his PhD from the prestigious Friedrich Miescher Institute, focusing on immunology and transcriptional regulation in B cells. His career highlights include significant contributions to the discovery of the JAK2 mutation, which has influenced therapeutic development in myeloproliferative neoplasms. Ralph has held various leadership roles at Novartis, where he has led drug discovery projects and mentored numerous students and postdocs. His expertise spans both translational research and team leadership in oncology. Ralph is passionate about advancing cancer therapies and fostering the next generation of researchers. He is fluent in English and has a deep commitment to innovation in the biomedical field. Outside of his professional endeavors, he enjoys mentoring and sharing knowledge with upcoming scientists.

Ralph`s contact details

mail

***********@novartis.com

******@monterosatx.com

Colleagues

avatar
Filip Janku

Chief Medical Officer

avatar
Ed Dunn

VP - Corporate Controller, Principal Accounting Officer

avatar
Karin Von Hodenberg

Vice President of Quality

avatar
Bernhard Fasching

Vice President, Chemistry at Monte Rosa Therapeutics

avatar
Debora Bonenfant

Vice-President, Head of Proteomics

avatar
Kevin Lumb

Vice President, Discovery Sciences

avatar
Chris King

VP of Nonclinical Development & Clinical Pharmacology

avatar
John Castle

Chief Information Officer

avatar
Jennifer Champoux

Chief Operating Officer

avatar
Alison Paterson

Vice President

View Contact details (it's free)
Request Profile Removal